Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chantry

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Oncogene|July 20, 2005
The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signallingStephen J Wicks, Katherine Haros, Marjorie Maillard, et al.
Oncogene|November 25, 2003
Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptorMorten P Oksvold, Christine B F Thien, Jannicke Widerberg, et al.
Biochimica Et Biophysica Acta|August 14, 2013
Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancerSurinder M Soond, Paul G Smith, Lloyd Wahl, et al.
Nucleic Acids Research|January 26, 2007
The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoterTimothy Grocott, Victoria Frost, Marjorie Maillard, et al.
RNA (New York, N.Y.)|January 15, 2010
Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein levelHelio Pais, Francisco Esteban Nicolas, Surinder M Soond, et al.
The Journal of Biological Chemistry|January 15, 2003
The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1Marie-Claire Hall, David A Young, Jasmine G Waters, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 3, 2024
Expanding the inhibitor space of the WWP1 and WWP2 HECT E3 ligasesAshley P Dudey, Jake M Rigby, Gregory R Hughes, et al.
Blood Advances|March 20, 2023
Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory studyStuart Scott, Richard Dillon, Christian Thiede, et al.
JBMR Plus|August 7, 2024
Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone diseaseHolly Evans, Rebecca Andrews, Fatma Ali Abedi, et al.
International Journal of Molecular Sciences|September 25, 2019
Smad7 Binds Differently to Individual and Tandem WW3 and WW4 Domains of WWP2 Ubiquitin Ligase IsoformsLloyd C Wahl, Jessica E Watt, Hiu T T Yim, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Oncogene|July 20, 2005
The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signallingStephen J Wicks, Katherine Haros, Marjorie Maillard, et al.
Oncogene|November 25, 2003
Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptorMorten P Oksvold, Christine B F Thien, Jannicke Widerberg, et al.
Biochimica Et Biophysica Acta|August 14, 2013
Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancerSurinder M Soond, Paul G Smith, Lloyd Wahl, et al.
Nucleic Acids Research|January 26, 2007
The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoterTimothy Grocott, Victoria Frost, Marjorie Maillard, et al.
RNA (New York, N.Y.)|January 15, 2010
Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein levelHelio Pais, Francisco Esteban Nicolas, Surinder M Soond, et al.
The Journal of Biological Chemistry|January 15, 2003
The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1Marie-Claire Hall, David A Young, Jasmine G Waters, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 3, 2024
Expanding the inhibitor space of the WWP1 and WWP2 HECT E3 ligasesAshley P Dudey, Jake M Rigby, Gregory R Hughes, et al.
Blood Advances|March 20, 2023
Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory studyStuart Scott, Richard Dillon, Christian Thiede, et al.
JBMR Plus|August 7, 2024
Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone diseaseHolly Evans, Rebecca Andrews, Fatma Ali Abedi, et al.
International Journal of Molecular Sciences|September 25, 2019
Smad7 Binds Differently to Individual and Tandem WW3 and WW4 Domains of WWP2 Ubiquitin Ligase IsoformsLloyd C Wahl, Jessica E Watt, Hiu T T Yim, et al.
Pageof 4